Press Releases

Date	Title	Company
20-Apr-2023	PharmaCord Announces Additional Facility Expansion in Support of Its Unprecedented Growth	Newswire
20-Apr-2023	Triple X Syndrome Management Market to expand at a 6% value CAGR by 2033 \| FMI Project	MARKITWIRED
20-Apr-2023	Enveda Biosciences Announces Oversubscribed Series B1 Bringing Total Round to US$119 Million	Businesswire
20-Apr-2023	Coulter Partners places Chief Scientific Officer at Sonata Therapeutics	Coulter Partners
20-Apr-2023	NHS Grampian and InnoScot Health team up to inspire workforce innovators	InnoScot Health
20-Apr-2023	Evaxion announces promising clinical data for DNA-based personalized cancer immunotherapy EVX-02: Phase 1/2a trial met both primary and secondary endpoints	Evaxion
20-Apr-2023	Roquette Cuts Ribbon on $25 Million Pharmaceutical Innovation Center in the United States	Roquette
20-Apr-2023	M1 Kliniken AG decides to start share buyback	M1 Kliniken AG
20-Apr-2023	OMass Therapeutics Announces New Phase of Growth with Move to New Facilities and Team Expansion to Support Portfolio Progress	OMass Therapeutics
20-Apr-2023	First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)	Businesswire
20-Apr-2023	KITE TO PRESENT NEW CAR T-CELL THERAPY DATA ACROSS MULTIPLE INDICATIONS AND MANUFACTURING EXPERIENCE AT EBMT 2023	Kite
20-Apr-2023	Eckert & Ziegler Receives Manufacturing Authorization for GMP-grade Lutetium-177	Eckert & Ziegler Strahlen- und Medizintechnik AG
20-Apr-2023	Elsevier launches EmBiology to deliver the unparalleled insights into biological activities that accelerate drug discovery	Elsevier
20-Apr-2023	VIRTUAL PATENT MARKING SOFTWARE TOOL, MARKRTM, LAUNCHED HELPING SAVE TIME AND MONEY FOR THE PHARMACEUTICALS INDUSTRY	Terrifio
20-Apr-2023	RotaChrom rCPC Platform Adheres to CGMP Guidelines for Pharmaceuticals	RotaChrom
20-Apr-2023	M1 Kliniken AG publishes preliminary figures for financial year 2022	M1 Kliniken AG
20-Apr-2023	Anti-Ageing Products, Services and Devices Market is anticipated to reach US$ 109.8 billion by 2033	MARKITWIRED
20-Apr-2023	Drug Formulation Market is expected to reach US$ 2.87 Triillion by 2032, exhibiting growth at a CAGR of 5.6%	MARKITWIRED
20-Apr-2023	Inhalation and Nasal Spray Generic Drugs Market is likely to register CAGR of 8.96% through 2033	MARKITWIRED
20-Apr-2023	Zika Virus Testing Market is expected to reach US$ 6.8 million by 2033, at a CAGR of 3.4%	MARKITWIRED